Tag Archives: health

We Are the Worldview

Worldview

Now in its 6th consecutive year, Scientific American Worldview: A Global Biotechnology Perspective will have its official launch in a special Super Session at the BIO International Convention today at 2pm. Moderated by television and radio personality David Brancaccio (Marketplace Morning; PBS Now) this exciting event will explore the ever-globalized ethos of life science innovation and examine the many multicultural elements driving new partnerships, new products and new paradigms. Scientific American Worldview is a collaborative Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

NIH, Patients and Industry Ramp Up to AMP-lify Innovation

Kay Holcomb

Speakers at Wednesday’s BIO 2014 Super Session – AMP-lifying Innovation: NIH, Patient Organizations & Leading Biopharma Firms Mobilize to Tackle Tough Diseases – discussed the new Accelerating Medicines Partnership (AMP) program, which is aimed at transforming the current model for developing new treatments by jointly identifying and validating promising biological targets of disease. AMP is a new venture among the NIH, several non-profit organizations and 10 biopharmaceutical companies focused on Alzheimer’s disease; type 2 diabetes Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Gates Foundation Issues Biotech Call to Action

Mundel

Today, Trevor Mundel from the Bill & Melinda Gates Foundation discussed the untapped potential of biotech companies to help develop new and better drugs, vaccines, diagnostics, and delivery systems for global health solutions at the 2014 BIO International Convention. This is important because 90 percent of the global infectious disease burden is borne by those who live in developing countries, yet the foundation believes that little attention is paid to health solutions to address these Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Reimbursement Considerations for Early Stage Companies

cells115x76

Panelists at Tuesday’s breakout session – Reimbursement Considerations for Early Stage Companies – overwhelmingly agreed that emerging biotech companies must consider reimbursement at the earliest stages of development. Christopher de Wolff, MSFS, Consultant, Numerof & Associates, Inc. moderated the panel and kicked it off by pointing out that many drugs achieve regulatory approval yet fail when they reach the market because of a lack of data and evidence directed at reimbursement. He asserted that the Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Integrate and Collaborate to Drive Advancements in Oncology Treatments

A New Paradigm in Oncology Treatment

Scientific innovation and exploration have driven exciting changes in the pharmaceutical industry’s understanding of cancer, from improvements in screening to the development of more personalized, treatments. In a 2014 BIO International Convention Super Session on Tuesday moderated by BioCentury Editor Susan Schaeffer, panelists discussed the pressing need for companies to increase collaboration with each other and with industry stakeholders, including patient advocacy groups and academic medical centers, to speed the development and delivery of new Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,